Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07833579
Enrolling by invitation Not applicable

Beetroot Juice and Neuromuscular Performance in Female Basketball Players

NCT07833579 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-09-22
Last updated
2026-09-22

Condition(s) studied

NitratePlacebo - Control

Investigational drug(s) / intervention(s)

PlaceboBeetroot juice supplementation

Placebo: Participants consumed one 70-mL serving of nitrate-depleted beetroot juice placebo (0.04 mmol of NO₃-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) daily for 5 consecutive days.

Beetroot juice supplementation: Participants consumed one 70-mL serving of nitrate-rich BJ (6.4 mmol of NO₃-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) daily for 5 consecutive days. On the final supplementation day, BJ was consumed 3 h before the testing session.

Study summary

A randomized, double-blind, placebo-controlled study investigates the effects of 5 days of nitrate-rich beetroot juice supplementation (70 mL·day-¹; 6.4 mmol NO₃-·day-¹) on physical performance in female basketball players. Performance will be evaluated using jump, 30-m sprint, agility, and isometric mid-thigh pull (IMTP) tests, while RPE and potential side effects will be assessed through questionnaires. The study aims to address the limited evidence regarding the ergogenic effects of beetroot juice supplementation in female team-sport athletes.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Female basketball players aged 18-35 years. * Currently participating in natitional competitive basketball. * Able to complete all supplementation and testing procedures. Exclusion Criteria: * Presence of any chronic disease or medical condition that could affect physical performance or interfere with the study procedures. * Presence of any injury during the month prior to the study that could limit participation in the physical performance tests. * Known intolerance or allergy to beetroot or other nitrate-rich vegetables (e.g., beetroot, lettuce). * Use of medications or dietary supplements that could potentially influence nitrate metabolism or physical performance during the study period.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad Pontificia Comillas Madrid Madrid

More Universidad Pontificia Comillas trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07833579 on ClinicalTrials.gov ↗ ← All trials in Spain